Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation

PHASE2CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

January 24, 2012

Primary Completion Date

March 10, 2014

Study Completion Date

March 10, 2014

Conditions
Atrial Fibrillation
Interventions
DRUG

Ranolazine

Tablets administered orally twice daily.

DRUG

Dronedarone

Capsule administered orally twice daily

DRUG

Ranolazine placebo

Tablets administered orally twice daily.

DRUG

Dronedarone placebo

Capsules administered orally twice daily

Trial Locations (50)

13501

Investigational Site, Utica

18101

Investigational Site, Afula

20010

Investigational Site, Washington D.C.

20912

Investigational Site, Takoma Park

21204

Investigational Site, Towson

22020

Investigational Site, Como

22100

Investigational Site, Nahariya

31096

Investigational Site, Haifa

33805

Investigational Site, Lakeland

37075

Investigational Site, Göttingen

38100

Investigational Site, Hadera

44106

Investigational Site, Cleveland

50134

Investigational Site, Florence

53105

Investigational Site, Bonn

54401

Investigational Site, Wausau

58100

Investigational Site, Holon

60594

Investigational Site, Frankfurt

76100

Investigational Site, Rehovot

77030

Investigational Site, Houston

78287

Investigational Site, Ashkelon

80012

Investigational Site, Aurora

81377

Investigational Site, München

84107

Investigational Site, Murray

85049

Investigational Site, Ingolstadt

90211

Investigational Site, Beverly Hills

91031

Investigational Site, Jerusalem

92663

Investigational Site, Newport Beach

94143

Investigational Site, San Francisco

96450

Investigational Site, Coburg

97080

Investigational Site, Würzburg

98122

Investigational Site, Seattle

02886

Investigational Site, Warwick

D23538

Investigational Site, Lübeck

6229 HX

Investigational Site, Maastricht

9700 RB

Investigational Site, Groningen

61-848

Investigational Site, Poznan

87-100

Investigational Site, Torun

31-501

Investigational Site, Krakow

01-211

Investigational Site, Warsaw

04-628

Investigational Site, Warsaw

15-276

Investigational Site, Bialystok

80-219

Investigational Site, Gdansk

81-717

Investigational Site, Sopot

40-635

Investigational Site, Katowice

41-800

Investigational Site, Zabrze

70-203

Investigational Site, Szczecin

91-425

Investigational Site, Lodz

02-097

Investigational Site, Warsaw

90-553

Investigational Site, Lodz

SE5 9RS

Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY